April 30 : U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for first-quarter profit and revenue, weighed down by softer demand for implants and devices used in complex procedures ranging from spinal to orthopedic surgeries. The company, which makes joint replacements and medical implants to repair broken bones, reiterated its expectations for adjusted annual profit in the range of $14.90 to $15.10 per share. Shares of the